Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Zomedica Corp.

Launch the TRUFORMA point-of-care diagnostic platform

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
19 Jan 2021
Due
30 Mar 2021
Delivered
30 Mar 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“approaching our planned March 30th commercial launch of TRUFORMA™, our point-of-care diagnostic platform”

What we found

Evidence strength A What the grades mean

Zomedica successfully launched the TRUFORMA diagnostic platform by the stated March 30, 2021 deadline, as confirmed by subsequent SEC filings referencing the commercial launch.

  • A
    Zomedica Corp. 10-Q filed 2021-05-12 Regulatory filing · published 12 May 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 0164712c246c
    “Following the commercial launch of TRUFORMA®, we expect to continue the development of another point-of-care diagnostic platform” ✓ confirmed on the page
  • A
    Zomedica Corp. 8-K filed 2021-05-17 Regulatory filing · published 17 May 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 18c5ff943666
    “As disclosed in our first quarter financials, Zomedica had a cash and cash equivalents balance of approximately $276.6 million as of March 31, 2021” ✓ confirmed on the page

Market reaction: the shares moved -12.9% against the S&P 500 over the three sessions around the disclosure (11 May 2021 to 14 May 2021). What this measures

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Commercial launch
Indicative materiality
Medium rules
Action
Launch
Deliverable
TRUFORMA diagnostic platform
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Zomedica Corp.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-ZOMDF-022157 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.